New pain block technique tested for heart surgery recovery
NCT ID NCT05320718
First seen Jun 26, 2026 · Last updated Jul 24, 2026 · Updated 3 times
Summary
This study compared two ways to control pain after minimally invasive heart bypass surgery: a newer erector spinae plane block (ESPB) versus the standard paravertebral block (PVB). 140 patients received one of the two blocks using the numbing drug ropivacaine. The goal was to see if ESPB works as well as PVB for pain relief, especially when coughing.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ropivacaine
- What this could lead to
- If successful, this could show that a newer, simpler nerve block (ESPB) is just as good as the standard one (PVB) for controlling pain after heart surgery.
- What could go wrong
- This is a small, completed study comparing two established techniques. The results may not apply to all heart surgeries or patients, and both blocks carry risks like bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
140 people
The number who actually took part.
- Started
-
Apr 2022
- Finished
-
Dec 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients undergoing elective minimally invasive direct coronary artery bypass grafting Exclusion Criteria: 1. Contraindications to regional anesthesia (coagulopathy, infection of the skin at the site of needle puncture area, et al) 2. Morbid obesity (body mass index \> 35 kg/m2) 3. Allergy to any of the study drugs 4. Chronic opioid use or history of opioid abuse. 5. Inability to understand pain score
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anesthesia, local are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Anesthesiology,Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
-
Peking University Third Hosptial
Beijing, 100191, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart bypass surgeons test which vein layout keeps grafts open
- A soft patch that watches your heart beat in real time
- Fixing broken ribs with surgery may cut pain better than drugs alone
- Zapping the ear: a new way to stop Post-Surgery heart rhythm problems?
- Squeeze a ball, lower your blood pressure? heart trial puts handgrip exercise to the test
- Two ways to numb the arm: which nerve block wins for hand surgery?